Israeli and American researchers uncovered the role of a specific enzyme in managing blood sugar levels in a study that opens up new therapeutic possibilities for people with type 2 diabetes. Type 2 ...
Semaglutide is associated with nonarteritic anterior ischemic optic neuropathy (NAION) among patients with type 2 diabetes (T2D) and those with overweight/obesity.
Objective—Glucagon-like peptide 1 (GLP-1) exerts beneficial antidiabetic actions via effects on pancreatic β- and α-cells. Previous studies have focused on the improvements in β-cell function ...
The deficiency or absence of glucagon in the counter-regulatory response to hypoglycemia in type 1 and type 2 diabetes mellitus has been known for a considerable time. The mechanism that underlies ...
This complex chemical cocktail is a dangerous defense, but it might also have beneficial qualities for humans as well. One hormone found in platypus venom, glucagon-like peptide-1 (GLP-1), plays a ...